Vistagen enters indemnification agreement with officer Dr. Angel S. Angelov

Vistagen Therapeutics executed an indemnification agreement effective May 18, 2026 with Dr. Angel S. Angelov, an officer of the company, to protect him against personal liability and advance legal expenses. The agreement includes standard change-of-control provisions and coverage under the company's directors' and officers' liability insurance.